Literature DB >> 27939845

Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma.

Cheng-Piao Luo1, Han-Yue Mo2, Ling-Ling Wu3, Yun Ma1, Ning-Fu Peng4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27939845     DOI： 10.1016/j.ejca.2016.09.040

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.

Authors:  Yu-Feng Yang; Ying-Hua Pan; Yun Cao; Jia Fu; Xia Yang; Mei-Fang Zhang; Qiu-Hong Tian
Journal:  Oncotarget       Date:  2017-07-18

2.  Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Shu-Yein Ho; Yi-Hsiang Huang; Yun-Hsuan Lee; Yi-You Chiou; Ting-Hui Hsieh; Tom Fang; Ya-Ju Tsai; Ming-Chih Hou; Teh-Ia Huo
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

3.  Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Shu-Yein Ho; Cheng-Yuan Hsia; Praneeth Kudaravalli; Yun-Hsuan Lee; Yi-You Chiou; Ya-Ju Tsai; Yi-Hsiang Huang; Teh-Ia Huo
Journal:  BMC Cancer       Date:  2018-03-14       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.